Company: CNTB
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001835268-25-000052
Chunk: 1

Company: Connect Biopharma Holdings Ltd
Filing Date: 2025-08-13
Form: 10-Q
Item: Part II, Item 1A
Chunk 1
---
 Linkbase DocumentFiled104Cover Page Interactive Data File (embedded within the Inline XBRL document and contained in Exhibit 101)Filed

†Management contract or compensatory plan, contract or arrangement.

# The certifications attached as Exhibit 32.1 that accompany this Quarterly Report on Form 10-Q are not deemed filed with the Securities and Exchange Commission and are not to be incorporated by reference into any filing of the Company under the Securities Act of 1933, as amended, or the Securities Exchange Act of 1934, as amended, whether made before or after the date of this Quarterly Report on Form 10-Q, irrespective of any general incorporation language contained in such filing.

26

TABLE OF CONTENTS

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.

Connect Biopharma Holdings LimitedDate: August 13, 2025/s/ Barry D. QuartBarry D. Quart, Pharm.D.Chief Executive Officer(Registrant’s Principal Executive Officer)/s/ Lisa PerazaLisa PerazaSenior Vice President of Finance(Registrant’s Principal Financial and Accounting Officer)

27